miR Scientific, LLC

miR Scientific, LLC

5
(119)
Écrire un avis
Plus
€ 17.99
Ajouter au panier
En Stock
Description

miR Scientific, LLC | 1 395 abonnés sur LinkedIn. miR Scientific is a healthcare company that is committed to transforming cancer management globally. | miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management Platform®, a proprietary, non-invasive platform for the effective management of targeted diseases, initially focused on urological cancers. The platform is powered by the miR Sentinel® Prostate Cancer Test, a liquid biopsy urine test that can accurately detect, classify, and monitor prostate cancer based on the interrogation of small-non-coding RNAs extracted from urinary exosomes. miR Scientific is developing interoperable products and services necessary to revolutionize the standards of care supporting urologic oncology, including for prostate, bladder, and other urothelial cancers.
miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management Platform®, a proprietary, non-invasive platform for the effective management of targeted diseases, initially focused on urological cancers. The platform is powered by the miR Sentinel® Prostate Cancer Test, a liquid biopsy urine test that can accurately detect, classify, and monitor prostate cancer based on the interrogation of small-non-coding RNAs extracted from urinary exosomes. miR Scientific is developing interoperable products and services necessary to revolutionize the standards of care supporting urologic oncology, including for prostate, bladder, and other urothelial cancers. Such new standards are urgently needed given the prevalence of these cancers and their debilitating burden globally. miR Scientific is a majority-owned operating subsidiary of Impact NRS LLC, headquartered in New York City with operating subsidiaries in Israel, Canada, and Puerto Rico.

miR Scientific, LLC on LinkedIn: #prostatecancer #cancer #accurate #noninvasive #urinetest…

Acerca de Nosotros

James Criss - miR Scientific, LLC

Molecular Diagnostic Prostate Cancer Test

miR Scientific, LLC

TransIT-mRNA Transfection Kit – 0.4 mL – Mirus Bio

miR Scientific - Crunchbase Company Profile & Funding

miR Scientific, LLC Overview

Rob Tenniswood - miR Scientific, LLC

Samantha Mall - Senior Research Associate - Assay Development - miR Scientific, LLC

MiR Scientific to light up need for prostate cancer testing

miR Scientific y el Gobierno de Puerto Rico se unen en la lucha para proclamar el Día de la Prevención del Cáncer de Próstata, primera causa de muerte por cáncer entre los

miR Scientific, LLC